The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis.

Ketan Kulkarni, Thomas Tran, Miles Medrano, Boris Yoffe, Richard Goodgame

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

GOALS: To evaluate the role of the discriminant factor in predicting mortality and deciding on treatment in acute alcoholic hepatitis. BACKGROUND: Current guidelines on the treatment of alcoholic hepatitis restrict the use of corticosteroids to patients with discriminant factor > 32 (severe disease) because of the toxicity of steroids. Less toxic forms of therapy, such as proxyphylline, may have a role in patients with lower discriminant factor, if mortality without therapy is common. STUDY: We performed a 5-year retrospective analysis comparing the outcomes of patients with mild and severe alcoholic hepatitis. Receiver operator characteristic curves were used to study the accuracy of the discriminant factor to predict short-term mortality. RESULTS: Among the 41 patients with severe alcoholic hepatitis (discriminant factor > 32) and 48 with mild alcoholic hepatitis, 16 (39%) and 8 (16.7%), respectively, died within 28 days of admission. Only 11 (32%) actually received corticosteroid therapy. The sensitivity and specificity of the discriminant factor in predicting mortality was 66.7% and 61.5%, respectively. A receiver operator characteristic curve of the discriminant factor gave the optimal value for the discriminant factor as 33, with the area under the curve being 0.666 (P = 0.0078; 95% CI = 0.531-0.801). CONCLUSIONS: Using the value of around 32 maximizes sensitivity and specificity of the discriminant factor in predicting mortality in alcoholic hepatitis. However, there is a high mortality in patients with alcoholic hepatitis and a discriminant factor less than 32. Alternative effective agents should be considered in patients with milder alcoholic hepatitis.

Original languageEnglish (US)
Pages (from-to)453-459
Number of pages7
JournalJournal of Clinical Gastroenterology
Volume38
Issue number5
StatePublished - May 2004
Externally publishedYes

Fingerprint

Alcoholic Hepatitis
Mortality
Therapeutics
Adrenal Cortex Hormones
Sensitivity and Specificity
Poisons
Area Under Curve
Steroids
Guidelines

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Kulkarni, K., Tran, T., Medrano, M., Yoffe, B., & Goodgame, R. (2004). The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis. Journal of Clinical Gastroenterology, 38(5), 453-459.

The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis. / Kulkarni, Ketan; Tran, Thomas; Medrano, Miles; Yoffe, Boris; Goodgame, Richard.

In: Journal of Clinical Gastroenterology, Vol. 38, No. 5, 05.2004, p. 453-459.

Research output: Contribution to journalArticle

Kulkarni, K, Tran, T, Medrano, M, Yoffe, B & Goodgame, R 2004, 'The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis.', Journal of Clinical Gastroenterology, vol. 38, no. 5, pp. 453-459.
Kulkarni, Ketan ; Tran, Thomas ; Medrano, Miles ; Yoffe, Boris ; Goodgame, Richard. / The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis. In: Journal of Clinical Gastroenterology. 2004 ; Vol. 38, No. 5. pp. 453-459.
@article{7b9b96c467034a629d22690bf96ec07d,
title = "The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis.",
abstract = "GOALS: To evaluate the role of the discriminant factor in predicting mortality and deciding on treatment in acute alcoholic hepatitis. BACKGROUND: Current guidelines on the treatment of alcoholic hepatitis restrict the use of corticosteroids to patients with discriminant factor > 32 (severe disease) because of the toxicity of steroids. Less toxic forms of therapy, such as proxyphylline, may have a role in patients with lower discriminant factor, if mortality without therapy is common. STUDY: We performed a 5-year retrospective analysis comparing the outcomes of patients with mild and severe alcoholic hepatitis. Receiver operator characteristic curves were used to study the accuracy of the discriminant factor to predict short-term mortality. RESULTS: Among the 41 patients with severe alcoholic hepatitis (discriminant factor > 32) and 48 with mild alcoholic hepatitis, 16 (39{\%}) and 8 (16.7{\%}), respectively, died within 28 days of admission. Only 11 (32{\%}) actually received corticosteroid therapy. The sensitivity and specificity of the discriminant factor in predicting mortality was 66.7{\%} and 61.5{\%}, respectively. A receiver operator characteristic curve of the discriminant factor gave the optimal value for the discriminant factor as 33, with the area under the curve being 0.666 (P = 0.0078; 95{\%} CI = 0.531-0.801). CONCLUSIONS: Using the value of around 32 maximizes sensitivity and specificity of the discriminant factor in predicting mortality in alcoholic hepatitis. However, there is a high mortality in patients with alcoholic hepatitis and a discriminant factor less than 32. Alternative effective agents should be considered in patients with milder alcoholic hepatitis.",
author = "Ketan Kulkarni and Thomas Tran and Miles Medrano and Boris Yoffe and Richard Goodgame",
year = "2004",
month = "5",
language = "English (US)",
volume = "38",
pages = "453--459",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis.

AU - Kulkarni, Ketan

AU - Tran, Thomas

AU - Medrano, Miles

AU - Yoffe, Boris

AU - Goodgame, Richard

PY - 2004/5

Y1 - 2004/5

N2 - GOALS: To evaluate the role of the discriminant factor in predicting mortality and deciding on treatment in acute alcoholic hepatitis. BACKGROUND: Current guidelines on the treatment of alcoholic hepatitis restrict the use of corticosteroids to patients with discriminant factor > 32 (severe disease) because of the toxicity of steroids. Less toxic forms of therapy, such as proxyphylline, may have a role in patients with lower discriminant factor, if mortality without therapy is common. STUDY: We performed a 5-year retrospective analysis comparing the outcomes of patients with mild and severe alcoholic hepatitis. Receiver operator characteristic curves were used to study the accuracy of the discriminant factor to predict short-term mortality. RESULTS: Among the 41 patients with severe alcoholic hepatitis (discriminant factor > 32) and 48 with mild alcoholic hepatitis, 16 (39%) and 8 (16.7%), respectively, died within 28 days of admission. Only 11 (32%) actually received corticosteroid therapy. The sensitivity and specificity of the discriminant factor in predicting mortality was 66.7% and 61.5%, respectively. A receiver operator characteristic curve of the discriminant factor gave the optimal value for the discriminant factor as 33, with the area under the curve being 0.666 (P = 0.0078; 95% CI = 0.531-0.801). CONCLUSIONS: Using the value of around 32 maximizes sensitivity and specificity of the discriminant factor in predicting mortality in alcoholic hepatitis. However, there is a high mortality in patients with alcoholic hepatitis and a discriminant factor less than 32. Alternative effective agents should be considered in patients with milder alcoholic hepatitis.

AB - GOALS: To evaluate the role of the discriminant factor in predicting mortality and deciding on treatment in acute alcoholic hepatitis. BACKGROUND: Current guidelines on the treatment of alcoholic hepatitis restrict the use of corticosteroids to patients with discriminant factor > 32 (severe disease) because of the toxicity of steroids. Less toxic forms of therapy, such as proxyphylline, may have a role in patients with lower discriminant factor, if mortality without therapy is common. STUDY: We performed a 5-year retrospective analysis comparing the outcomes of patients with mild and severe alcoholic hepatitis. Receiver operator characteristic curves were used to study the accuracy of the discriminant factor to predict short-term mortality. RESULTS: Among the 41 patients with severe alcoholic hepatitis (discriminant factor > 32) and 48 with mild alcoholic hepatitis, 16 (39%) and 8 (16.7%), respectively, died within 28 days of admission. Only 11 (32%) actually received corticosteroid therapy. The sensitivity and specificity of the discriminant factor in predicting mortality was 66.7% and 61.5%, respectively. A receiver operator characteristic curve of the discriminant factor gave the optimal value for the discriminant factor as 33, with the area under the curve being 0.666 (P = 0.0078; 95% CI = 0.531-0.801). CONCLUSIONS: Using the value of around 32 maximizes sensitivity and specificity of the discriminant factor in predicting mortality in alcoholic hepatitis. However, there is a high mortality in patients with alcoholic hepatitis and a discriminant factor less than 32. Alternative effective agents should be considered in patients with milder alcoholic hepatitis.

UR - http://www.scopus.com/inward/record.url?scp=4344715978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344715978&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 453

EP - 459

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 5

ER -